Characteristics | N = 2171 | Survival N = 1585 | Mortality N = 586 | p value |
---|---|---|---|---|
Age (mean (SD)) | 64.86 (14.00) | 63.97 (14.31) | 67.31 (12.80) | < 0.001 |
BNP pg/ml (mean (SD)) | 5973.17 (13668.52) | 5788.88 (13520.08) | 6553.00 (14150.27) | 0.525 |
Troponin I ng/ml (mean (SD)) | 4.19 (21.03) | 3.00 (16.52) | 7.16 (29.19) | < 0.001 |
Troponin T ng/ml (mean (SD)) | 0.50 (2.25) | 0.59 (2.67) | 0.31 (0.68) | 0.447 |
WBC counts (mean (SD)) | 19.83 (12.69) | 19.00 (10.74) | 22.07 (16.69) | < 0.001 |
CHF, n (%) | 398 (18.3) | 290 (18.3) | 108 (18.4) | 0.993 |
Diabetes, n (%) | 736 (33.9) | 540 (34.1) | 196 (33.4) | 0.825 |
Hypertension, n (%) | 1123 (51.7) | 834 (52.6) | 289 (49.3) | 0.188 |
COPD, n(%) | 425 (19.6) | 301 (19.0) | 124 (21.2) | 0.285 |
Cirrhosis, n (%) | 110 (5.1) | 58 (3.7) | 52 (8.9) | < 0.001 |
Tumor, n (%) | 341 (15.7) | 213 (13.4) | 128 (21.8) | < 0.001 |
Chronic Respiratory Failure, , n (%) | 52 (2.4) | 33 (2.1) | 19 (3.2) | 0.158 |
CHD, n (%) | 420 (19.3) | 278 (17.5) | 142 (24.2) | 0.001 |
Chronic Renal Failure, n (%) | 229 (10.5) | 155 (9.8) | 74 (12.6) | 0.066 |
Dialysis, n (%) | 603 (27.8) | 456 (28.8) | 147 (25.1) | 0.099 |
Ventilation proportion, n (%) | 2064 (95.1) | 1499 (94.6) | 565 (96.4) | 0.099 |
Weight (mean (SD)) | 85.11 (28.86) | 85.84 (28.81) | 83.11 (28.95) | 0.051 |
Height (mean (SD)) | 169.43 (12.25) | 169.55 (12.06) | 169.11 (12.74) | 0.457 |
Ethnicity, n (%) | 0.809 | |||
African American | 150 (6.9) | 114 (7.2) | 36 (6.1) | |
Asian | 26 (1.2) | 19 (1.2) | 7 (1.2) | |
Caucasian | 1718 (79.1) | 1247 (78.7) | 471 (80.4) | |
Hispanic | 139 (6.4) | 105 (6.6) | 34 (5.8) | |
Native American | 19 (0.9) | 12 (0.8) | 7 (1.2) | |
Other/Unknown | 119 (5.5) | 88 (5.6) | 31 (5.3) | |
Acute Physiology score (mean (SD)) | 74.24 (29.47) | 69.43 (26.18) | 87.25 (33.68) | < 0.001 |
APACHE IV score (mean (SD)) | 87.38 (30.64) | 81.87 (27.31) | 102.27 (34.04) | < 0.001 |
Dexmedetomidine, n (%) | 438 (20.2) | 363 (22.9) | 75 (12.8) | < 0.001 |
Propofol, n (%) | 1598 (73.6) | 1203 (75.9) | 395 (67.4) | < 0.001 |
Midazolam, n (%) | 658 (30.3) | 420 (26.5) | 238 (40.6) | < 0.001 |
Lymphocyte (mean (SD)) | 9.33 (10.41) | 9.49 (10.04) | 8.87 (11.46) | 0.292 |
Sex = Male, n (%) | 1213 (55.9) | 876 (55.3) | 337 (57.5) | 0.376 |
Norepinephrine, n (%) | 1300 (59.88) | 813 (51.29) | 487 (83.1) | < 0.001 |
Dopamine, n (%) | 129 (6.0) | 67 (4.2) | 62 (10.7) | < 0.001 |
Dobutamine, n (%) | 113 (5.2) | 63 (4.0) | 50 (8.6) | < 0.001 |
Dex + Pro, n (%) | 233 (10.7) | 197 (12.4) | 36 (6.1) | < 0.001 |
Dex + Mid, n (%) | 53 (2.4) | 40 (2.5) | 13 (2.2) | 0.801 |
Pro + Mid, n (%) | 238 (11.0) | 165 (10.4) | 73 (12.5) | 0.201 |